Shares Up on Deal and Guidance Confirmation

  • Owens & Minor shares rise after agreeing to buy Rotech Healthcare Holdings
  • Deal valued at $1.36 billion in cash
  • Rotech to become a wholly owned subsidiary of Owens & Minor
  • 2024 revenue expected between $10.5B and $10.9B, adjusted EPS $1.40-$1.70
  • Second-quarter adjusted EPS forecast at 32-36 cents
  • Net loss projected due to income tax charge related to past transfer pricing methodology

Owens & Minor’s shares increased after announcing the acquisition of Rotech Healthcare Holdings and reiterating its 2024 guidance. The deal, valued at $1.36 billion in cash, will see Rotech become a wholly owned subsidiary of Owens & Minor. The company expects revenue between $10.5B and $10.9B and an adjusted EPS of $1.40-$1.70 for 2024. Second-quarter adjusted EPS forecast is 32-36 cents, while a net loss is projected due to past transfer pricing methodology’s income tax charge.

Factuality Level: 10
Factuality Justification: The article provides accurate and objective information about the acquisition of Rotech Healthcare Holdings by Owens & Minor, including financial details and projections for the company’s future performance.
Noise Level: 3
Noise Justification: The article provides relevant information about a corporate acquisition and financial projections, but lacks in-depth analysis or exploration of long-term trends or consequences for stakeholders.
Public Companies: Owens & Minor (OMI)
Private Companies: Rotech Healthcare Holdings
Key People: Josh Beckerman (Author)

Track all markets on TradingView

Financial Relevance: Yes
Financial Markets Impacted: Owens & Minor and Rotech Healthcare Holdings stocks
Financial Rating Justification: The article discusses a merger between two healthcare companies, Owens & Minor and Rotech Healthcare Holdings, which will impact the stocks of both companies. It also mentions the financial guidance for 2024 and the expected earnings per share for the second quarter.
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Extreme Rating Justification: There is no mention of an extreme event in this article.

Reported publicly: www.marketwatch.com